Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients-Reference-Cited by-同舟云学术

Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients

Published:2022-10-27 Issue:23-24 Volume:134 Page:883-891
ISSN:0043-5325
Container-title:Wiener klinische Wochenschrift
language:en
Short-container-title:Wien Klin Wochenschr

Author:

Karolyi Mario^ORCID,Kaltenegger Lukas,Pawelka Erich^ORCID,Kuran Avelino,Platzer Moritz,Totschnig David,Koenig Franz,Hoepler Wolfgang,Laferl Hermann^ORCID,Omid Sara,Seitz Tamara,Traugott Marianna,Arthofer Sigrun,Erlbeck Lea,Jaeger Stefan,Kettenbach Alina,Assinger Alice,Wenisch Christoph,Zoufaly Alexander

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00508-022-02098-9.pdf

Reference33 articles.

1. Aleissa MM, Silverman EA, Paredes Acosta LM, Nutt CT, Richterman A, Marty FM. New perspectives on antimicrobial agents: Remdesivir treatment for COVID-19. antimicrob Agents Chemother. 2020;65(1):e1814–e20. https://doi.org/10.1128/AAC.01814-20.

2. Mulangu S, Dodd LE, Davey RT Jr, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293–303. https://doi.org/10.1056/NEJMoa1910993.

3. Amani B, Khanijahani A, Amani B. Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials. Sci Rep. 2021;11(1):11974. https://doi.org/10.1038/s41598-021-91089-3.

4. WHO Solidarity Trial Consortium, Pan H, Peto R, et al. Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results. N Engl J Med. 2020; https://doi.org/10.1056/NEJMoa2023184.

5. RECOVERY Collaborative Group. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020;396(10259):1345–52. https://doi.org/10.1016/S0140-6736(20)32013-4.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and effectiveness of remdesivir in a postmarketing surveillance study in Japan;Respiratory Investigation;2024-03

2. Remdesivir for the Treatment of COVID-19: A Narrative Review;Infectious Diseases and Therapy;2024-01

3. Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis;Expert Review of Anti-infective Therapy;2023-09-02

4. Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings;Journal of Clinical Medicine;2023-03-19

5. Doctor’s Orders;Patients’ Lived Experiences During the Transplant and Cellular Therapy Journey;2023